ATRIAL FIBRILLATION
Time courses and quantitative analysis of atrial fibrillation episode number and duration after circular plus linear left atrial lesions
Trigger elimination or substrate modification: Early or delayed cure?
Hans Kottkamp, MD*,
Hildegard Tanner, MD,
Richard Kobza, MD,
Petra Schirdewahn, MD,
Anja Dorszewski, MD,
Jin-Hong Gerds-Li, MD,
Corrado Carbucicchio, MD,
Christopher Piorkowski, MD and
Gerhard Hindricks, MD
University of Leipzig, Heart Center, Cardiology, Department of Electrophysiology, Leipzig, Germany
Manuscript received January 29, 2004;
revised manuscript received April 22, 2004,
accepted April 27, 2004.
* Reprint requests and correspondence: Prof. Dr. Hans Kottkamp, University of Leipzig, Heart Center, Cardiology, Department of Electrophysiology, Struempellstrasse 39, D-04289 Leipzig, Germany
(Email: Kotth{at}medizin.uni-leipzig.de).
OBJECTIVES: We sought to analyze the time course of atrial fibrillation (AF) episodes before and after circular plus linear left atrial ablation and the percentage of patients with complete freedom from AF after ablation by using serial seven-day electrocardiograms (ECGs).
BACKGROUND: The curative treatment of AF targets the pathophysiological corner stones of AF (i.e., the initiating triggers and/or the perpetuation of AF). The pathophysiological complexity of both may not result in an "all-or-nothing" response but may modify number and duration of AF episodes.
METHODS: In patients with highly symptomatic AF, circular plus linear ablation lesions were placed around the left and right pulmonary veins, between the two circles, and from the left circle to the mitral annulus using the electroanatomic mapping system. Repetitive continuous 7-day ECGs administered before and after catheter ablation were used for rhythm follow-up.
RESULTS: In 100 patients with paroxysmal (n = 80) and persistent (n = 20) AF, relative duration of time spent in AF significantly decreased over time (35 ± 37% before ablation, 26 ± 41% directly after ablation, and 10 ± 22% after 12 months). Freedom from AF stepwise increased in patients with paroxysmal AF and after 12 months measured at 88% or 74% depending on whether 24-h ECG or 7-day ECG was used. Complete pulmonary vein isolation was demonstrated in <20% of the circular lesions.
CONCLUSIONS: The results obtained in patients with AF treated with circular plus linear left atrial lesions strongly indicate that substrate modification is the main underlying pathophysiologic mechanism and that it results in a delayed cure instead of an immediate cure.
|
Abbreviations and Acronyms
| | AF = atrial fibrillation | | ANOVA = analysis of variance | | ECG = electrocardiogram | | IRAAF = Intraoperative Radiofrequency Ablation of Atrial Fibrillation study | | PV = pulmonary vein |
|
This article has been cited by other articles:

|
 |

|
 |
 
S. Knecht, M. Hocini, M. Wright, N. Lellouche, M. D. O'Neill, S. Matsuo, I. Nault, V. S. Chauhan, K. J. Makati, M. Bevilacqua, et al.
Left atrial linear lesions are required for successful treatment of persistent atrial fibrillation
Eur. Heart J.,
October 1, 2008;
29(19):
2359 - 2366.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. G. Katritsis
Catheter Ablation of Atrial Fibrillation: For Whom and How?
Angiology,
August 1, 2008;
59(2_suppl):
103S - 106S.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Neumann, J. Vogt, B. Schumacher, A. Dorszewski, M. Kuniss, H. Neuser, K. Kurzidim, A. Berkowitsch, M. Koller, J. Heintze, et al.
Circumferential Pulmonary Vein Isolation With the Cryoballoon Technique: Results From a Prospective 3-Center Study
J. Am. Coll. Cardiol.,
July 22, 2008;
52(4):
273 - 278.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Noheria, A. Kumar, J. V. Wylie Jr, and M. E. Josephson
Catheter Ablation vs Antiarrhythmic Drug Therapy for Atrial Fibrillation: A Systematic Review
Arch Intern Med,
March 24, 2008;
168(6):
581 - 586.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. E.W. Hemels, J. H. Ruiter, G. P. Molhoek, N. J.G.M. Veeger, A. C.P. Wiesfeld, A. V. Ranchor, M. van Trigt, A. Pilmeyer, I. C. Van Gelder, and for The Features in AT500TM study; Chances for pat
Right atrial preventive and antitachycardia pacing for prevention of paroxysmal atrial fibrillation in patients without bradycardia: a randomized study
Europace,
March 1, 2008;
10(3):
306 - 313.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. G. Katritsis and A. J. Camm
Catheter ablation of atrial fibrillation: do we know what we are doing?
Europace,
November 1, 2007;
9(11):
1002 - 1005.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. D. O'Neill, P. Jais, M. Hocini, F. Sacher, G. J. Klein, J. Clementy, and M. Haissaguerre
Catheter Ablation for Atrial Fibrillation
Circulation,
September 25, 2007;
116(13):
1515 - 1523.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Dagres, C. Piorkowski, H. Kottkamp, D. Th. Kremastinos, and G. Hindricks
Contemporary catheter ablation of arrhythmias in geriatric patients: patient characteristics, distribution of arrhythmias, and outcome
Europace,
July 1, 2007;
9(7):
477 - 480.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Calkins, J. Brugada, D. L. Packer, R. Cappato, S.-A. Chen, H. J.G. Crijns, R. J. Damiano Jr, D. W. Davies, D. E. Haines, M. Haissaguerre, et al.
HRS/EHRA/ECAS Expert Consensus Statement on Catheter and Surgical Ablation of Atrial Fibrillation: Recommendations for Personnel, Policy, Procedures and Follow-Up: A report of the Heart Rhythm Society (HRS) Task Force on Catheter and Surgical Ablation of Atrial Fibrillation Developed in partnership with the European Heart Rhythm Association (EHRA) and the European Cardiac Arrhythmia Society (ECAS); in collaboration with the American College of Cardiology (ACC), American Heart Association (AHA), and the Society of Thoracic Surgeons (STS). Endorsed and Approved by the governing bodies of the American College of Cardiology, the American Heart Association, the European Cardiac Arrhythmia Society, the European Heart Rhythm Association, the Society of Thoracic Surgeons, and the Heart Rhythm Society.
Europace,
June 1, 2007;
9(6):
335 - 379.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Calo, F. Lamberti, M. L. Loricchio, E. De Ruvo, F. Colivicchi, L. Bianconi, C. Pandozi, and M. Santini
Left Atrial Ablation Versus Biatrial Ablation for Persistent and Permanent Atrial Fibrillation: A Prospective and Randomized Study
J. Am. Coll. Cardiol.,
June 20, 2006;
47(12):
2504 - 2512.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Oral, C. Pappone, A. Chugh, E. Good, F. Bogun, F. Pelosi Jr., E. R. Bates, M. H. Lehmann, G. Vicedomini, G. Augello, et al.
Circumferential pulmonary-vein ablation for chronic atrial fibrillation.
N. Engl. J. Med.,
March 2, 2006;
354(9):
934 - 941.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. H. Shuhaiber and J. T. Reston
Reply to mishra.
Eur. J. Cardiothorac. Surg.,
March 1, 2006;
29(3):
425 - 426.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Stabile, E. Bertaglia, G. Senatore, A. De Simone, F. Zoppo, G. Donnici, P. Turco, P. Pascotto, M. Fazzari, and D. F. Vitale
Catheter ablation treatment in patients with drug-refractory atrial fibrillation: a prospective, multi-centre, randomized, controlled study (Catheter Ablation For The Cure Of Atrial Fibrillation Study)
Eur. Heart J.,
January 2, 2006;
27(2):
216 - 221.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. E. Accord, R.-J. van Suylen, T. J. van Brakel, and J. G. Maessen
Post-Mortem Histologic Evaluation of Microwave Lesions After Epicardial Pulmonary Vein Isolation for Atrial Fibrillation
Ann. Thorac. Surg.,
September 1, 2005;
80(3):
881 - 887.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Verma, F. Kilicaslan, E. Pisano, N. F. Marrouche, R. Fanelli, J. Brachmann, J. Geunther, D. Potenza, D. O. Martin, J. Cummings, et al.
Response of Atrial Fibrillation to Pulmonary Vein Antrum Isolation Is Directly Related to Resumption and Delay of Pulmonary Vein Conduction
Circulation,
August 2, 2005;
112(5):
627 - 635.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Tanner, G. Hindricks, R. Kobza, A. Dorszewski, P. Schirdewahn, C. Piorkowski, J.-H. Gerds-Li, and H. Kottkamp
Trigger Activity More Than Three Years After Left Atrial Linear Ablation Without Pulmonary Vein Isolation in Patients With Atrial Fibrillation
J. Am. Coll. Cardiol.,
July 19, 2005;
46(2):
338 - 343.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Hindricks, C. Piorkowski, H. Tanner, R. Kobza, J.-H. Gerds-Li, C. Carbucicchio, and H. Kottkamp
Perception of Atrial Fibrillation Before and After Radiofrequency Catheter Ablation: Relevance of Asymptomatic Arrhythmia Recurrence
Circulation,
July 19, 2005;
112(3):
307 - 313.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Senatore, G. Stabile, E. Bertaglia, G. Donnici, A. De Simone, F. Zoppo, P. Turco, P. Pascotto, and M. Fazzari
Role of transtelephonic electrocardiographic monitoring in detecting short-term arrhythmia recurrences after radiofrequency ablation in patients with atrial fibrillation
J. Am. Coll. Cardiol.,
March 15, 2005;
45(6):
873 - 876.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. N. DeMaria, O. Ben-Yehuda, D. Berman, G. K. Feld, B. H. Greenberg, J. D. Knoke, K. U. Knowlton, W. Y.W. Lew, J. Narula, D. Sahn, et al.
Highlights of the year in JACC 2004
J. Am. Coll. Cardiol.,
January 4, 2005;
45(1):
137 - 153.
[Full Text]
[PDF]
|
 |
|
|